Karyopharm Therapeutics

Prezzo Delle Azioni
9.23
Cambio Giornaliero
-0.36 -3.75%
Mensile
46.51%
Annuale
44.90%
Q1 Previsione
9.12




Ebit Cambiamento Data
AbbVie USD 5.81B 4.36B 2025-12
Abbott USD 2.54B 358M 2025-12
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BioCryst Pharmaceuticals USD -4.51M 12.2M 2024-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Incyte USD 383.88M 47.44M 2025-12
J&J USD 5.11B 2.3B 2025-12
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
MacroGenics USD 20.16M 55.51M 2025-09
Merck USD 6.24B 1.32B 2025-12
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Novartis USD -9.19B 13.87B 2025-06
Novartis USD 4.48B 343M 2025-09
Pfizer USD 4.65B 71M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Takeda JPY 257.49B 568.56B 2025-12
Tectonic Therapeutic USD -22.33M 4.03M 2025-06
TG Therapeutics USD 50.49M 21.13M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Xencor USD -53.63M 6.11M 2025-12


Karyopharm Therapeutics - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.